Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 47
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Gastric cancer screening in Western countries: A call to action 2024 Farinati, FabioPelizzaro, Filippo DIGESTIVE AND LIVER DISEASE - -
Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care 2024 Pelizzaro, FilippoVitale, Alessandro + DIGESTIVE AND LIVER DISEASE - -
Liver resection versus radiofrequency ablation or trans-arterial chemoembolization for early-stage (BCLC A) oligo-nodular hepatocellular carcinoma: meta-analysis 2024 Ilaria BillatoFrancesco D’AmicoGiovanni MarchegianiFilippo PelizzaroAlessandro VitaleUmberto Cillo + BJS OPEN - -
Patient journey in gastroesophageal reflux disease: real-world perspectives from Italian gastroenterologists, primary care physicians, and ENT specialists 2024 Pelizzaro, FilippoSavarino, Edoardo Vincenzo + THERAPEUTIC ADVANCES IN GASTROENTEROLOGY - -
Crosstalk between MicroRNAs and Oxidative Stress in Coeliac Disease 2024 Pelizzaro, FilippoCardin, RomildaMinotto, MilenaCarlotto, ChiaraFassan, MatteoPalo, MichelaFarinati, FabioZingone, Fabiana + INFLAMMATORY INTESTINAL DISEASES - -
Characteristics and outcome of anti‐hepatitis D virus positive patients with hepatocellular carcinoma 2024 Pelizzaro, FilippoSacerdoti, DavidVitale, Alessandro + LIVER INTERNATIONAL - -
Efficacy of immunotherapy in hepatocellular carcinoma: Does liver disease etiology have a role? 2023 Russo, Francesco PaoloPelizzaro, FilippoGambato, Martina + DIGESTIVE AND LIVER DISEASE - -
HIF-1α and VEGF as prognostic biomarkers in hepatocellular carcinoma patients treated with transarterial chemoembolization 2023 Pelizzaro, FilippoCardin, RomildaRusso, Francesco Paolo + DIGESTIVE AND LIVER DISEASE - -
Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection 2023 Pelizzaro, FilippoVitale, AlessandroCillo, Umberto + LIVER INTERNATIONAL - -
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Strategies and Biomarkers Predicting Response and/or Resistance 2023 Pelizzaro, FilippoFarinati, Fabio + BIOMEDICINES - -
A rare cause of painful hepatomegaly 2023 Zanetto, AlbertoPelizzaro, FilippoRizzo, Stefania + JOURNAL OF HEPATOLOGY - -
Toward a more precise prognostic stratification in acute decompensation of cirrhosis: The Padua model 2.0 2023 Zanetto, AlbertoPelizzaro, FilippoFerrarese, AlbertoSimioni, PaoloBasso, DanielaBurra, Patrizia + UNITED EUROPEAN GASTROENTEROLOGY JOURNAL - -
Refractory celiac disease and its mimickers: a review on pathogenesis, clinical-pathological features and therapeutic challenges 2023 Pizzi, MarcoPelizzaro, FilippoDei Tos, Angelo PaoloPiazza, FrancescoSavarino, Edoardo VincenzoZingone, FabianaFassan, Matteo + FRONTIERS IN ONCOLOGY - -
Multiple hepatic cysts in an adult male 2023 Zanetto, AlbertoPelizzaro, FilippoSbaraglia, Marta + JOURNAL OF HEPATOLOGY - -
Angiogenesis and Hepatocellular Carcinoma: From Molecular Mechanisms to Systemic Therapies 2023 Pelizzaro, FilippoFarinati, FabioRusso, Francesco Paolo + MEDICINA - -
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database 2023 Vitale, AlessandroPelizzaro, FilippoRamirez Morales, RafaelCillo, UmbertoMarchesini, GiulioFarinati, Fabio + GUT - -
BIOMARCATORI CIRCOLANTI E FATTORI CLINICI ASSOCIATI CON LA PROGNOSI NEI PAZIENTI CON CARCINOMA EPATOCELLULARE 2022 PELIZZARO, FILIPPO - - -
Severity of systemic inflammation is the main predictor of ACLF and bleeding in patients with acutely decompensated cirrhosis 2022 Zanetto, AlbertoPelizzaro, FilippoCampello, ElenaBulato, CristianaGavasso, SabrinaSaggiorato, GraziellaRusso, Francesco PaoloBurra, PatriziaSimioni, PaoloSenzolo, Marco + JOURNAL OF HEPATOLOGY - -
Impact of SARS-CoV-2 Pandemic on the Management of Patients with Hepatocellular Carcinoma 2022 Pelizzaro, FilippoRusso, Francesco PaoloVitale, Alessandro + JOURNAL OF CLINICAL MEDICINE - -
Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative Treatment 2022 Pelizzaro F.Haxhi S.Penzo B.Vitale A.Farinati F. + FRONTIERS IN ONCOLOGY - -
Mostrati risultati da 1 a 20 di 47
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile